EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma by Landgren, Ola, Prior, Thomas J., Masterson, Tara, Heuck, Christoph, Bueno, Orlando F., Dash, Ajeeta B., Einsele, Hermann, Goldschmidt, Hartmut, Knop, Stefan, Li, Cong, Mellqvist, Ulf-Henrik, McFadden, Ian, Oprea, Corina, Ross, Jeremy A., Talpes, Mihaela, Hydren, Jay R., Ahlstrom, Jennifer M., Kazandjian, Dickran, Weinhold, Niels, Zhang, Rick, Stetler-Stevenson, Maryalice, Marti, Gerald, Devlin, Sean M.

Get full text